MEDINCELL by Medincell (MDCLF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

34.39 - 34.39

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Medincell SA News

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study

Here's a roundup of top developments in the biotech space over the last 24 hours.

Vandana Singh

FDA Rejects Teva - MedinCell's Schizophrenia Candidate

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-24.55M

Investing Cash Flow (TTM)

-10.51M

Financing Cash Flow (TTM)

38.82M

Free Cash Flow (TTM)

-26.60M

Capital Expenditure (TTM)

-2.04M

Net Change in Cash (TTM)

3.76M

Valuation Metrics

Enterprise Value

$974.00M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$55.02M

LT Debt

$52.39M

LT Debt Issuance (TTM)

$570.00K

LT Debt Repayment (TTM)

-$4.65M

Total Cash

$62.79M

Debt to Equity

18.74

Issuance of Debt (TTM)

-$4.08M

Repayment of Debt (TTM)

-$4.65M

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

34.39 - 34.39

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Pharmaceuticals

Medincell SA is a clinical- and commercial-stage biopharmaceutical company developing and licensing long-acting injectable treatments across multiple therapeutic areas, combining its proprietary BEPO technology with active ingredients already known a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

MDCLF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

MDCLF

FAQ

How do I buy MEDINCELL by Medincell (MDCLF) stock?

You can purchase shares of MEDINCELL by Medincell (OTCEM:MDCLF) through any online brokerage.

View our list of the best stock brokerages

Who are MEDINCELL by Medincell (MDCLF) competitors?

There are no as such competitors for MEDINCELL by Medincell.

What is the forecast, or price target, for MEDINCELL by Medincell (MDCLF) stock?

There is no analysis for MEDINCELL by Medincell to provide a consensus price target.

What is the current price for MEDINCELL by Medincell (MDCLF)?

The stock price for MEDINCELL by Medincell (OTCEM: MDCLF) is $34.39 last updated January 23, 2026 at 3:44 PM EST.

Does MEDINCELL by Medincell (MDCLF) pay a dividend?

There are no upcoming dividends for MEDINCELL by Medincell.

When is MEDINCELL by Medincell (OTCEM:MDCLF) reporting earnings?

MEDINCELL by Medincell does not have any upcoming earnings scheduled.

Is MEDINCELL by Medincell (MDCLF) going to split?

There is no upcoming split for MEDINCELL by Medincell.

What sector and industry does MEDINCELL by Medincell (MDCLF) operate in?

MEDINCELL by Medincell is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.

Benzinga

Benzinga